Cargando…
Cascading After Peridiagnostic Cancer Genetic Testing: An Alternative to Population-Based Screening
PURPOSE: Despite advances in DNA sequencing technology and expanded medical guidelines, the vast majority of individuals carrying pathogenic variants of common cancer susceptibility genes have yet to be identified. An alternative to population-wide genetic screening of healthy individuals would expl...
Autores principales: | Offit, Kenneth, Tkachuk, Kaitlyn A., Stadler, Zsofia K., Walsh, Michael F., Diaz-Zabala, Hector, Levin, Jeffrey D., Steinsnyder, Zoe, Ravichandran, Vignesh, Sharaf, Ravi N., Frey, Melissa K., Lipkin, Steven M., Robson, Mark E., Hamilton, Jada G., Vijai, Joseph, Mukherjee, Semanti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Clinical Oncology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193752/ https://www.ncbi.nlm.nih.gov/pubmed/31922925 http://dx.doi.org/10.1200/JCO.19.02010 |
Ejemplares similares
-
Towards Automation of Germline Variant Curation in Clinical Cancer Genetics
por: Ravichandran, Vignesh, et al.
Publicado: (2019) -
NBN Pathogenic Germline Variants are Associated with Pan-Cancer Susceptibility and In Vitro DNA Damage Response Defects
por: Belhadj, Sami, et al.
Publicado: (2023) -
Development of a novel measure of advanced cancer patients’ perceived utility of secondary germline findings from tumor genomic profiling
por: Hamilton, Jada G., et al.
Publicado: (2023) -
Pathogenic Loss-of-Function Germline TERT Mutations in Patients With Solid Tumors
por: Walsh, Michael F., et al.
Publicado: (2019) -
Germline RAD51B variants confer susceptibility to breast and ovarian cancers deficient in homologous recombination
por: Setton, Jeremy, et al.
Publicado: (2021)